Insights of gut-liver axis in hepatic diseases: Mechanisms, clinical implications, and therapeutic potentials

doi:10.4292/wjgpt.v15.i6.98146

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (408)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

HTML

282

Figures (1-3)

Tables (1-2)

Sum=310

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=64

Publishing Process of This Article

Item

Count

Browse

Download

Sum=28

Nov 5, 2024 (publication date) through Nov 1, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Pharmacol Ther. Nov 5, 2024; 15(6): 98146
Published online Nov 5, 2024. doi: 10.4292/wjgpt.v15.i6.98146

Open in New Tab Full Size Figure Download Figure

Figure 1 Role of gut microbiota in maintaining liver homeostasis. IgA: Immunoglobulin A; IL: Interleukin; MAMP: Microbe-associated molecular patterns; PAMP: Pathogen-associated molecular patterns; TGF: Transforming growth factor; TNF: Tumor necrosis factor.

Open in New Tab Full Size Figure Download Figure

Figure 2 Dysbiotic gut-liver axis resulting in liver damage. IL: Interleukin; LPS: Lipopolysaccharide; M: Macrophage; KCs: Kupffer cells; DAMP: Damage-associated molecular patterns; PAMP: Pathogen-associated molecular patterns; TNF: Tumor necrosis factor.

Open in New Tab Full Size Figure Download Figure

Figure 3 Therapeutic potential of intestinal microbiome in liver disease management.

Citation: Jeyaraman N, Jeyaraman M, Mariappan T, Muthu S, Ramasubramanian S, Sharma S, Santos GS, da Fonseca LF, Lana JF. Insights of gut-liver axis in hepatic diseases: Mechanisms, clinical implications, and therapeutic potentials. World J Gastrointest Pharmacol Ther 2024; 15(6): 98146
URL: https://www.wjgnet.com/2150-5349/full/v15/i6/98146.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v15.i6.98146